Chairman & CEO Berman will participate in Chardan Capital Market’s upcoming biotech leadership conference call to be held on January 30 at 10:30 am.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on COYA:
- Coya Therapeutics Boosts Finances with Dr. Reddy’s Deal
- Coya expands pipeline for COYA 302 beyond ALS to include FTD and PD
- Coya announces pre-IND meeting, Type C meeting with FDA for COYA 302
- Coya Therapeutics files to sell 4.69M shares of common stock for holders
- Coya Therapeutics’ CEO gives update, sufficient cash for COYA 302 Phase 2 trial